ClinicalTrials.Veeva

Menu

Acute Effect of Crocus Sativus on Postprandial Glycemia

A

Agricultural University of Athens

Status

Completed

Conditions

Appetitive Behavior
Potential Abnormality of Glucose Tolerance
Blood Pressure

Treatments

Other: D-Glucose beverage as reference food
Other: 15mg of Crocus Sativus as beverage
Other: 30mg of Crocus Sativus as beverage

Study type

Interventional

Funder types

Other

Identifiers

NCT05484362
HRBD 58/21.06.2022

Details and patient eligibility

About

This study investigated the effects of two different doses of Crocus Sativus in glucose beverages on glycemic responses.

Full description

This study examined the short-term effects of two different doses (15 mg and 30 mg) of Crocus Sativus in glucose beverages on postprandial glycemic responses in healthy young adults.

Enrollment

11 patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy
  • Non-smoking
  • Non-diabetic men and women
  • Body Mass Index (BMI) between 18.5 and 24.9 kg/m2
  • Normal blood pressure

Exclusion criteria

  • Severe chronic disease (e.g., coronary heart disease, diabetes mellitus, kidney or liver conditions, endocrine conditions)
  • Gastrointestinal disorders
  • Pregnancy
  • Lactation
  • Competitive sports
  • Alcohol abuse
  • Drug dependency
  • Allergy in Crocus Sativus

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

11 participants in 3 patient groups

Glucose as reference food
Experimental group
Description:
Eleven healthy subjects (male: 6, female: 5) after 10-14h fast, consumed 50 g D-glucose, three times, in different weeks along with 250 mL water; and 50 g D-glucose containing 15 mg and 30 mg of Crocus Sativus tested once, in different weeks along with 250 mL water. Fingertip capillary blood glucose samples were taken at 0, 15, 30, 45, 60, 90 and 120 min postmeal. The first glucose sample was taken exactly 15 min after the beginning of the consumption of the tested beverage.
Treatment:
Other: D-Glucose beverage as reference food
Other: 15mg of Crocus Sativus as beverage
Other: 30mg of Crocus Sativus as beverage
15mg of Crocus Sativus as beverage
Experimental group
Description:
Eleven healthy subjects (male: 6, female: 5) after 10-14h fast, consumed 50 g D-glucose, three times, in different weeks along with 250 mL water; and 50 g D-glucose containing 15 mg and 30 mg of Crocus Sativus tested once, in different weeks along with 250 mL water. Fingertip capillary blood glucose samples were taken at 0, 15, 30, 45, 60, 90 and 120 min postmeal. The first glucose sample was taken exactly 15 min after the beginning of the consumption of the tested beverage.
Treatment:
Other: D-Glucose beverage as reference food
Other: 15mg of Crocus Sativus as beverage
Other: 30mg of Crocus Sativus as beverage
30mg of Crocus Sativus as beverage
Experimental group
Description:
Eleven healthy subjects (male: 6, female: 5) after 10-14h fast, consumed 50 g D-glucose, three times, in different weeks along with 250 mL water; and 50 g D-glucose containing 15 mg and 30 mg of Crocus Sativus tested once, in different weeks along with 250 mL water. Fingertip capillary blood glucose samples were taken at 0, 15, 30, 45, 60, 90 and 120 min postmeal. The first glucose sample was taken exactly 15 min after the beginning of the consumption of the tested beverage.
Treatment:
Other: D-Glucose beverage as reference food
Other: 15mg of Crocus Sativus as beverage
Other: 30mg of Crocus Sativus as beverage

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems